Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 314
Industry Insight
Overcoming CAR T-Cell Therapy Limitations
In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and innovative manufacturing strategies are overcoming the key limitations of autologous CAR T-cell therapy.
Industry Insight
Tackling Rare Diseases With RNA Therapeutics
To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff Milton, at the 2025 SLAS international meeting in San Diego.
Article
Weight Loss and Diabetes Drugs: What’s the Latest Research?
Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But reports of unpleasant side effects have prompted further studies. This article explores the latest research on these drugs.
Article
New Year's Resolution To Lose Weight? Avoid Counterfeit Weight Loss Drugs
High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market. So, what are the dangers of counterfeits? And what can consumers look out for?
News
Psychedelic Therapy May Help Improve Cancer Patients’ Mental Health
The “magic mushroom” psychedelic compound – psilocybin – may help to improve mental health symptoms faced by cancer patients when used alongside psychotherapy.
Infographic
Host Cell Protein Analysis: Approaches and Advances
Biopharmaceuticals and biotherapeutics are medicines produced from living cells. But cells produce other proteins (called host cell proteins, or HCPs) that can contaminate the final therapeutic product and cause a number of problems.
Article
How Is AI Being Used in Drug Discovery?
This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.
Industry Insight
Research Partnership Aims To Advance Fragment-Based Cancer Drug Discovery
Cancer Research Horizons and Diamond Light Source aim to strengthen their partnership, combining their expertise and resources to bring new cancer treatments to patients.
News
Bacteria Could Be Targets for a Colon Cancer Vaccine
Two bacterial strains may be linked to higher rates of colon cancer in some countries. This may provide a target for the development of measures such as vaccines to cut rates of colon cancer.
News
Weight Loss Drug Shrinks Heart Muscle in Mice and Human Cells
Weight loss drugs like semaglutide may shrink heart muscle as well as waistlines, according to a new study. It found that the popular drug decreased heart muscle mass in lean and obese mice.
Advertisement
